Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

GeneDx Holdings Raises FY2025 Sales Guidance from $400.000M-$415.000M to $425.000M-$428.000M vs $411.682M Est

Author: Benzinga Newsdesk | October 28, 2025 05:32am
GeneDx Holdings (NASDAQ:WGS) raises FY2025 sales outlook from $400.000 million-$415.000 million to $425.000 million-$428.000 million vs $411.682 million estimate.

Posted In: WGS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist